174 related articles for article (PubMed ID: 11788428)
1. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion.
Reffelmann T; Hale SL; Li G; Kloner RA
Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H766-72. PubMed ID: 11788428
[TBL] [Abstract][Full Text] [Related]
2. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit.
Reffelmann T; Kloner RA
Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H1099-107. PubMed ID: 12181140
[TBL] [Abstract][Full Text] [Related]
3. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion.
Hale SL; Mehra A; Leeka J; Kloner RA
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H421-5. PubMed ID: 17993599
[TBL] [Abstract][Full Text] [Related]
4. Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction.
Hale SL; Dae MW; Kloner RA
Cardiovasc Res; 2003 Sep; 59(3):715-22. PubMed ID: 14499873
[TBL] [Abstract][Full Text] [Related]
5. The effect of CY1503, a sialyl Lewisx analog blocker of the selectin adhesion molecules, on infarct size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion.
Birnbaum Y; Patterson M; Kloner RA
J Mol Cell Cardiol; 1997 Aug; 29(8):2013-25. PubMed ID: 9281435
[TBL] [Abstract][Full Text] [Related]
6. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.
Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289
[TBL] [Abstract][Full Text] [Related]
7. Thoracic epidural anesthesia reduces infarct size in a canine model of myocardial ischemia and reperfusion injury.
Groban L; Zvara DA; Deal DD; Vernon JC; Carpenter RL
J Cardiothorac Vasc Anesth; 1999 Oct; 13(5):579-85. PubMed ID: 10527228
[TBL] [Abstract][Full Text] [Related]
8. Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation.
Reffelmann T; Kloner RA
Cardiovasc Res; 2003 Aug; 59(2):441-9. PubMed ID: 12909327
[TBL] [Abstract][Full Text] [Related]
9. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
[TBL] [Abstract][Full Text] [Related]
10. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
[TBL] [Abstract][Full Text] [Related]
11. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography.
Jeremy RW; Links JM; Becker LC
J Am Coll Cardiol; 1990 Sep; 16(3):695-704. PubMed ID: 2387943
[TBL] [Abstract][Full Text] [Related]
12. Serial measurement of hFABP and high-sensitivity troponin I post-PCI in STEMI: how fast and accurate can myocardial infarct size and no-reflow be predicted?
Uitterdijk A; Sneep S; van Duin RW; Krabbendam-Peters I; Gorsse-Bakker C; Duncker DJ; van der Giessen WJ; van Beusekom HM
Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1104-10. PubMed ID: 23873799
[TBL] [Abstract][Full Text] [Related]
13. Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart.
Preckel B; Schlack W; Gonzàlez M; Obal D; Barthel H; Thämer V
Basic Res Cardiol; 2000 Oct; 95(5):404-12. PubMed ID: 11099168
[TBL] [Abstract][Full Text] [Related]
14. Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage?
Reffelmann T; Kloner RA
Am J Physiol Heart Circ Physiol; 2003 Apr; 284(4):H1134-41. PubMed ID: 12388217
[TBL] [Abstract][Full Text] [Related]
15. Influence of leukopenia on collateral flow, reperfusion flow, reflow ventricular fibrillation, and infarct size in dogs.
de Lorgeril M; Basmadjian A; Lavallée M; Clément R; Millette D; Rousseau G; Latour JG
Am Heart J; 1989 Mar; 117(3):523-32. PubMed ID: 2919531
[TBL] [Abstract][Full Text] [Related]
16. Deterioration in myocardial blood flow following relief of sustained ischemia is not associated with release of endothelin into the coronary sinus.
Przyklenk K; Simkhovich BZ; Bauer B; Kloner RA
Basic Res Cardiol; 1994; 89(3):260-9. PubMed ID: 7945162
[TBL] [Abstract][Full Text] [Related]
17. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model.
Dai W; Hale S; Kloner RA
Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128
[TBL] [Abstract][Full Text] [Related]
18. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
[TBL] [Abstract][Full Text] [Related]
19. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion.
Reffelmann T; Hale SL; Dow JS; Kloner RA
Circulation; 2003 Dec; 108(23):2911-7. PubMed ID: 14656914
[TBL] [Abstract][Full Text] [Related]
20. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size.
Hale SL; Herring MJ; Kloner RA
J Am Heart Assoc; 2013 Jan; 2(1):e004234. PubMed ID: 23525431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
